Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Unda 38 12 X Drops ; Granules ; Liquid ; Pellet ; Tablet is a Health Canada–registered human drug (DIN 02233257) held by Seroyal International Inc., containing Aluminum. Health Canada lists its status as Cancelled Post Market (status date 06 Jul 2009). Nexara Health has matched 2 registrations of Aluminum across 1 other regulated market.

Health Canada registration

DIN02233257
Brand nameUnda 38
Active ingredientAluminum
Strength12 X
Dosage formDrops ; Granules ; Liquid ; Pellet ; Tablet
RouteOral
CompanySeroyal International Inc.
StatusCancelled Post Market — 06 Jul 2009
ClassHuman
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Aluminum registered in other markets

2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesAluminum metallicumBoironPelletlistedFDA NDC
United StatesAluminum metallicumBoironPelletlistedFDA NDC

See every manufacturer of Aluminum worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Unda 38 (DIN 02233257) marketed in Canada?

No. Health Canada lists DIN 02233257 as Cancelled Post Market as of 06 Jul 2009.

Who holds the Canadian licence for this product?

Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.

Is Aluminum registered outside Canada?

Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02233257, status date 2009-07-06; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02233257, status date 2009-07-06; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02233257, status date 2009-07-06; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.